Cash Flow Statement
Growth Metrics

Harvard Bioscience (HBIO) Other Working Capital Changes (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Other Working Capital Changes for 16 consecutive years, with -$1.1 million as the latest value for Q4 2025.

  • Quarterly Other Working Capital Changes fell 33.66% to -$1.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.5 million through Dec 2025, up 7.37% year-over-year, with the annual reading at -$1.5 million for FY2025, 7.37% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$1.1 million at Harvard Bioscience, down from -$16000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $741000.0 in Q1 2023, with the low at -$1.6 million in Q4 2023.
  • Average Other Working Capital Changes over 5 years is -$239150.0, with a median of -$88500.0 recorded in 2021.
  • The sharpest move saw Other Working Capital Changes soared 1471.43% in 2022, then plummeted 334.94% in 2023.
  • Over 5 years, Other Working Capital Changes stood at $647000.0 in 2021, then tumbled by 298.61% to -$1.3 million in 2022, then fell by 24.59% to -$1.6 million in 2023, then surged by 48.59% to -$823000.0 in 2024, then plummeted by 33.66% to -$1.1 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$1.1 million, -$16000.0, and -$376000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.